Welcome to our dedicated page for Check Cap SEC filings (Ticker: CHEK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Access SEC filings for Check-Cap Ltd (CHEK), documenting both the company's history as a medical diagnostics business and its corporate transformation into an AI enterprise through merger with MBody AI. As a foreign private issuer based in Israel, Check-Cap filed regular 6-K reports to disclose material events, providing transparency into corporate developments.
Check-Cap's historical filings reveal the challenges and progress of a clinical-stage medical device company developing colorectal cancer screening technology. The 6-K forms document clinical trial updates, regulatory interactions, financing activities, and strategic decisions that shaped the company's trajectory. For investors researching the medical diagnostics sector, these filings offer insights into the development pathway for innovative imaging technologies.
The most significant filings cover the merger transaction with MBody AI, including proxy materials for shareholder voting, business combination agreements, and disclosures about the transformed corporate structure. These documents explain how Check-Cap transitioned from a healthcare technology company to an artificial intelligence business, marking a fundamental change in the company's operations and market positioning.
Our platform provides easy access to all Check-Cap filings with AI-powered summaries that explain complex regulatory language. Track the company's evolution from medical device development through corporate transformation by reviewing 6-K material event reports, proxy statements, and transaction documents that chronicle this significant business pivot.
Check-Cap Ltd. submitted a Form 6-K to furnish its consolidated unaudited financial statements as of and for the six months ended June 30, 2025. These interim results are provided as Exhibit 99.1, along with related Inline XBRL data files. The filing also states that this report is incorporated by reference into Check-Cap’s existing registration statements on Form F-3 and Form S-8, meaning those shelf and equity compensation registrations now also cover the information in these latest financial statements.
Check-Cap (CHEK) furnished a Form 6-K highlighting MBody AI’s enterprise traction and an upcoming merger vote on November 14. The filing describes MBody AI’s hardware-agnostic Orchestrator platform as the integration layer for robots and intelligent devices across factories, hotels, hospitals, and data centers. Reported outcomes from organizations using the platform include up to 40 percent labor reduction and 80 percent uptime improvement.
MBody AI notes multi-year, multi-million-dollar enterprise contracts, Fortune 500 and blue-chip deployments, and growing investor interest from major funds, family offices, and strategics totaling into the hundreds of millions of dollars. Company leaders frame the merger as positioning CHEK shareholders within embodied AI, supported by forward-looking statements that caution that actual results may differ due to market conditions, regulatory approvals, and integration risks.
Check-Cap Ltd. (CHEK) rescheduled its Annual General Meeting to November 14, 2025 at 10:00 a.m. ET at Paul Hastings LLP in Washington, DC. Shareholders of record as of September 16, 2025 may vote. The proxy materials previously furnished are incorporated by reference, with an updated Reverse Split Proposal range of 1-for-2 to 1-for-100. The number of authorized ordinary shares will remain 18,000,000, and the nominal value will remain NIS 48.0 per share even if the reverse split is approved.
The company also provided an update on its proposed merger with MBody AI. Under the September 12, 2025 Merger Agreement, a Check-Cap subsidiary will merge into MBody AI, which will survive as a wholly owned subsidiary of Check-Cap. The Board affirmed that the originally disclosed exchange ratio is being preserved. Subject to satisfaction or waiver of closing conditions and shareholder approval, the parties expect to consummate the merger in the weeks following approval.
Check-Cap (CHEK) furnished a business update on its pending merger with MBody AI and recent market activity. The company reported exceptional capital-markets engagement following the merger announcement, noting its shares increased by more than 300% and trading volumes reached the hundreds of millions of dollars in the days after the news.
The Board is evaluating potential financing opportunities to support the combined company’s growth strategy. No securities are being offered by this Form 6-K; any future financing would be conducted in compliance with applicable laws and regulations.
To allow additional time to assess financing options and amid elevated investor engagement, Check-Cap will reschedule its Annual General Meeting of Shareholders (originally set for October 17, 2025) and expects to announce a new date and record date in a subsequent Form 6-K.
FAQ
What is the current stock price of Check Cap (CHEK)?
What is the market cap of Check Cap (CHEK)?
